SAGE Therapeutics ( (SAGE) ) has provided an update.
On March 3, 2025, Sage Therapeutics announced the resignation of its Chief Medical Officer, Dr. Laura Gault, effective March 21, 2025, as she pursues a new opportunity. The company has appointed its current Chief Scientific Officer, Dr. Mike Quirk, to take over key responsibilities on an interim basis, ensuring continuity in strategic guidance for its clinical development programs.
More about SAGE Therapeutics
YTD Price Performance: 26.30%
Average Trading Volume: 1,973,395
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $448.8M
For an in-depth examination of SAGE stock, go to TipRanks’ Stock Analysis page.